Yahoo Finance published this video item, entitled “Biogen’s Alzheimer’s drug could generate ‘$8 billion in peak sales’: Analyst” – below is their description.
#Biogen #alzheimers #yahoofinance
Mizuho Americas Senior Biotech Analyst Salim Syed joins Yahoo Finance Live anchors Julie Hyman and Brad Smith to discuss encouraging Phase 3 data from Biogen’s Alzheimer’s treatment lecanemab, how many sales the drug could generate, and what this means for the pharmaceutical industry.
Yahoo Finance YouTube Channel
Got a comment? Leave your thoughts in the comments section, below. Please note comments are moderated before publication.